| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 0 | 38.661 | 77.720 | 102.268 | 113.298 |
| Total Income - EUR | - | - | - | - | - | 0 | 38.665 | 77.723 | 102.317 | 113.318 |
| Total Expenses - EUR | - | - | - | - | - | 167 | 6.629 | 18.984 | 42.532 | 71.384 |
| Gross Profit/Loss - EUR | - | - | - | - | - | -167 | 32.036 | 58.739 | 59.785 | 41.934 |
| Net Profit/Loss - EUR | - | - | - | - | - | -167 | 30.915 | 57.346 | 58.824 | 39.176 |
| Employees | - | - | - | - | - | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Oftamed Cherim S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 47 | 4.968 | 24.118 | 31.489 | 57.782 |
| Current Assets | - | - | - | - | - | 163 | 38.750 | 58.560 | 67.326 | 100.104 |
| Inventories | - | - | - | - | - | 0 | 0 | 587 | 0 | 649 |
| Receivables | - | - | - | - | - | 0 | 1.403 | 35.667 | 23.618 | 32.113 |
| Cash | - | - | - | - | - | 163 | 37.347 | 22.306 | 43.709 | 67.342 |
| Shareholders Funds | - | - | - | - | - | -125 | 30.792 | 57.395 | 83.302 | 106.646 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 336 | 12.927 | 25.283 | 15.513 | 51.240 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Oftamed Cherim S.r.l.